EGFR and lung carcinoma: The epidermal growth factor receptor (EGFR) that regulates cell proliferation, apoptosis, angiogenesis and tumor invasion [11] is over-expressed or in certain cases affected by oncogenic mutations in NSCLC and is one of the major target for lung cancer therapy.